🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is to evaluate pharmacokinetics (PK), pharmacodynamics (PD) and ...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-10-23
Trial ID
NCT02000804
Treatments Being Tested
Subjects will receive their first dose of darapladib in the clinical resear...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-05
Trial ID
NCT00704431
Treatments Being Tested
The overall objective of this integrated analysis is to evaluate the clinic...
Status
Completed
Location
Multiple Locations
Start Date
2011-10
Trial ID
NCT01636271
Treatments Being Tested
This study will determine the effect of single and repeat administration of...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-06-19
Trial ID
NCT01873339
Treatments Being Tested
AIM III is a prospective, randomized, double-blinded, placebo controlled tr...
Status
Completed
Location
Mayo Clinic
Start Date
2010-02-04
Trial ID
NCT01067339
Treatments Being Tested
The purpose of this study is to characterize the systemic and ocular safety...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-02
Trial ID
NCT01506895
Treatments Being Tested
This will be an exploratory, open-label, single sequence, two part study (P...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-02-26
Trial ID
NCT02058641
Treatments Being Tested
The potential for a drug interaction between Darapladib and Rosuvastatin is...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-12-17
Trial ID
NCT01751074
Treatments Being Tested
Darapladib (SB-480848) is a novel, selective, orally active inhibitor of li...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-05-14
Trial ID
NCT01852565
Treatments Being Tested
In accordance with the recently revised FDA draft renal impairment guidance...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-10-29
Trial ID
NCT01711723
Treatments Being Tested